mo:re launches lab platform to set a new standard in animal-free drug development 🚀 The Hamburg-based life science start-up mo:re announced the launch of their first product at the #SLAS2025 in San Diego, the world’s leading trade show in laboratory automation 🧫 mo:re introduces a laboratory platform to automate the planning, culture, and analysis of complex 3D cell culture models. The user-friendly platform enables verifiable, standardized results without requiring expertise in specific organ systems. 💰 The commercialization is backed by a #seed financing round of €2.3 million from international investors, led by HTGF | High-Tech Gründerfonds, with participation from IFB Innovationsstarter GmbH, Gilson, NEDGEX, Nidobirds Ventures, and Private Investors.
Congratulations!
🔗 Full Release: https://more.science/files/More-seed-press-release.pdf
Congratulations to the mo:re Team! Well done and well deserved! I am very happy to be part of the exciting journey ahead! 🚀
Wow, congrats to this milestone mo:re! 🚀
Congratulations! 🚀
Congratulations to this amazing success! 🎉
Herzlichen Glückwunsch an mo:re! 🎉 Ein beeindruckender Meilenstein für das Hamburg-basierte Startup aus der Technischen Universität Hamburg. Mit ihrer innovativen Laborplattform setzen sie neue Standards in der tierversuchsfreien Medikamentenentwicklung und eröffnen neue Möglichkeiten für die Life Sciences! 🌱🔬 Wir sind stolz auf euer Erfolg und freuen uns auf die nächsten Schritte!
Huge shout out to the #more Team for this great financing success - way to go and #OnwardsAndUpwards
🎉 Congratulations to the entire mo:re team! NETZSCH-Gerätebau GmbH is proud to support your mission to transform cell culture workflows and set new standards in animal-free drug development. 💚
Congrats!